PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.39%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.05%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-49.95%
Negative operating income growth while 0354.HK is at 14.40%. Joel Greenblatt would press for urgent turnaround measures.
-11.57%
Negative net income growth while 0354.HK stands at 1.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.80%
Negative EPS growth while 0354.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-10.80%
Negative diluted EPS growth while 0354.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.83%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.83%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-125.46%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-125.55%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-64.23%
Negative 10Y revenue/share CAGR while 0354.HK stands at 299.17%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-63.34%
Negative 5Y CAGR while 0354.HK stands at 113.06%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-63.63%
Negative 3Y CAGR while 0354.HK stands at 68.32%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-231.27%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-246.17%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
49.50%
3Y OCF/share CAGR above 1.5x 0354.HK's 8.89%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-77.53%
Negative 10Y net income/share CAGR while 0354.HK is at 327.83%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-41.50%
Negative 5Y net income/share CAGR while 0354.HK is 166.98%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-51.85%
Negative 3Y CAGR while 0354.HK is 34.62%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
2.52%
Below 50% of 0354.HK's 99.04%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-1.93%
Negative 3Y equity/share growth while 0354.HK is at 54.42%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-51.20%
Negative 5Y dividend/share CAGR while 0354.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-15.61%
Negative near-term dividend growth while 0354.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
2.61%
AR growth is negative/stable vs. 0354.HK's 10.59%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-13.49%
Inventory is declining while 0354.HK stands at 108.56%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-11.95%
Negative asset growth while 0354.HK invests at 7.70%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.49%
Under 50% of 0354.HK's 8.62%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-60.19%
We’re deleveraging while 0354.HK stands at 35.65%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-18.87%
We cut SG&A while 0354.HK invests at 56.17%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.